Zacks Buy List Highlights: Stein Mart, Inc., Acuity Brands, Inc., Cascade Bancorp, and Aspreva Pharmaceuticals Corporation.CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today are Stein Mart Stein Mart NASDAQ: SMRT is a chain of department stores that sells boutique, apparel, footwear, linens and home decor. Stein Mart, Inc. is based in Jacksonville, Florida, and describes itself as "a hybrid between a better department/specialty store and a traditional , Inc. (Nasdaq: SMRT SMRT Smart SMRT Singapore Mass Rapid Transit SMRT Silencing Mediator for Retinoid and Thyroid Hormone Receptors SMRT Section for Magnetic Resonance Technologists SMRT Sampling Modeling and Research Technology SMRT Single Message-Unit Rate Timing SMRT Signal Message Rate Timing ), Acuity Brands Acuity Brands, Inc., through its subsidiaries, engages in the design, production, and distribution of lighting equipment and specialty products worldwide. The company was founded in 2001 and is based in Atlanta, Georgia. , Inc. (NYSE NYSE See: New York Stock Exchange : AYI AYI Academy of Young Investors ), Cascade Bancorp (Nasdaq: CACB CACB Canadian Architectural Certification Board CACB Canadian Academy of Clinical Biochemistry CACB Center Aisle Connector Bracket ), and Aspreva Pharmaceuticals Corporation (Nasdaq: ASPV). Stocks ranked #1 (Strong Buy) by Zacks have produced an average annual return of +33% since inception in 1988. During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8% while the S&P 500 tumbled 37.6%. To see the full Zacks #1 Rank (Strong Buy) List, or the rank for any other stock, visit: http://at.zacks.com/?id=88 Here is a synopsis of today's Zacks Rank Buy Stocks: Aggressive Growth - Stein Mart, Inc. (Nasdaq: SMRT) Stein Mart, Inc. has a consistent history of exceeding earnings estimates. SMRT has done so in 10 of the past 12 quarters, with the other two matching estimates. Three analysts have raised their numbers for this year as well as for next year. Earnings estimates have been on the rise for both this year and next. Over the past 60 days, this year's numbers have risen 10% to $1.11 per share, while next year's estimates have increased 3.8% to $1.35 per share. Growth & Income - Acuity Brands, Inc. (NYSE: AYI) Acuity Brands, Inc. recently posted record quarterly results, which included all-time highs in net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight , net income and earnings per share. The Board of Directors at AYI approved the repurchase of an additional two million shares of common stock and declared a quarterly dividend of 15 cents per share Cents per share The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned. . The company is currently yielding 1.5% and has a five-year average dividend yield of 2.7%. Momentum - Cascade Bancorp (Nasdaq: CACB) Cascade Bancorp announced earnings on July 13 at 41 cents per share versus 28 cents last year. This amounted to a 32% positive earnings surprise. CACB has been in a long gradual uptrend uptrend A series of price increases in a security or in the general market. Some investors believe a security tends to take on a certain inertia; as a result, these investors search for stock in an uptrend, thinking that it will probably continue to move in , yet before the Jun earnings report, CACB appeared to have topped out at the end of March when the stock hit a high of $30.43. Since that time, the stock had sold off 13%. Clearly at the very least, CACB needs to find a new, higher level of value to reflect the improvement in the company's financials. Value - Aspreva Pharmaceuticals Corporation (Nasdaq: ASPV) Aspreva Pharmaceuticals Corporation, a Zacks #1 Rank stock, recently topped the Street's earnings estimate by an eye-popping 111.9%. Earnings per share are projected to grow by a healthy 20% over the next 3-5 years, with industry growth forecasted to be 18%. Consensus estimates have been shooting upward for ASPV. The company has a return on equity of 51%, compared to -44% for the industry average. Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report, "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions," provides an insightful background about this wealth-building tool. Download your free copy of the report now to prosper in the years to come by visiting http://at.zacks.com/?id=93. About the Zacks Rank Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." A $10,000 investment in the Zacks Rank list made in 1988 would now be worth $1.82 million - equivalent to a 33% annualized annualized Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared. return! During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8%, while the S&P 500 tumbled 37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 129.7% annually (+5.2% vs. +11.9%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively. Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day" subscribe, take buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company"; this free newsletter today by visiting http://at.zacks.com/?id=90. About Zacks Zacks.com is a property of Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. , Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=91 Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. (a) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment Reinvestment Using dividends, interest and capital gains earned in an investment or mutual fund to purchase additional shares or units, rather than receiving the distributions in cash. 1. In terms of stocks, it is the reinvestment of dividends to purchase additional shares. of all dividends, no transaction costs Transaction Costs Costs incurred when buying or selling securities. These include brokers' commissions and spreads (the difference between the price the dealer paid for a security and the price they can sell it). , and represents the gross returns before management fees. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion